Clinical Updates

news-preview-placeholder
Micardis Generic Release

The generic equivalent of Micardis tablets (telmisartan) has just been released, following FDA approval. Micardis…

Jan 13, 2014
news-preview-placeholder
REMOVAL OF CODEINE FROM THE MARKET

In its January 10, 2014 notice in the Federal Register, the FDA ordered drug companies…

Jan 10, 2014
news-preview-placeholder
Generic Detrol LA Capsules®

On Thursday, January 2, Teva Pharmaceuticals launched the generic equivalent of Detrol LA® extended-release capsules…

Jan 02, 2014
news-preview-placeholder
Cymbalta® Delayed-Release Capsule Launch

Effective December 11, 2013, the generic equivalent of Cymbalta® delayed-release capsules (duloxetine HCI) was released,…

Dec 11, 2013
news-preview-placeholder
Launch of Generic Aciphex® 20mg Tablets

On Friday, November 8, Lupin Pharmaceuticals, Inc., launched the generic equivalent of Aciphex® delayed-release tablets…

Nov 11, 2013
news-preview-placeholder
FDA Approval for ZORVOLEX™

October 18, 2013 – Iroko Pharmaceuticals, LLC, announced that the FDA had approved ZORVOLEX™ (diclofenac)…

Oct 18, 2013
news-preview-placeholder
Launch of Generic Niaspan® Extended-Release Tablets

Teva Pharmaceuticals has launched generic Niaspan® Extended-Release Tablets, which received FDA Approval in April 2005…

Sep 24, 2013
news-preview-placeholder
Generic Lidoderm 5% Patch Launches

Actavis Pharma, Inc. has launched generic Lidoderm® (lidocaine patch 5%), which received FDA approval on…

Sep 17, 2013
news-preview-placeholder
Generic Trilipix Capsules Launch

On July 15, 2013, Global Pharmaceuticals received final FDA approval and commenced shipping for generic…

Aug 01, 2013
news-preview-placeholder
Generic Zomig Launches

On May 14, 2013, Global Pharmaceuticals launched the Authorized Generic (AG) for Zomig and Zomig-ZMT…

May 20, 2013
  • This field is for validation purposes and should be left unchanged.


Filter Articles

Should a claimant need this much pain medication for this long? Are claimants utilizing medications or selling on the black market?

The prevalence of opioid use and abuse among those with chronic pain has developed into one of the most pressing issues today. Download the white paper to learn facts about the opioid crisis and possible solutions to avoid prescriptions that could lead to abuse.

Download Now